Overview

This trial is active, not recruiting.

Conditions prediabetes, cardiovascular risk factors
Treatment observational, no intervention needed
Sponsor Chinese University of Hong Kong
Start date November 2008
End date December 2018
Trial size 3000 participants
Trial identifier NCT00786890, ADF-2008-2

Summary

Hypothesis: A high cardiovascular risk is present in subjects with pre-diabetes in Hong Kong Chinese.

The investigators plan to assess Chinese subjects in Hong Kong who have pre-diabetes (impaired fasting glucose, IFG; or impaired glucose tolerance, IGT) based on oral glucose tolerance test (OGTT) on their cardiovascular risk status such as obesity, hypertension and lipid profile.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Observational model case-only
Time perspective prospective
Arm
observational, no treatment needed
observational, no intervention needed
observational, no intervention needed

Primary Outcomes

Measure
Cardiovascular risk factors: anthroprometric parameters, blood pressure and lipid profiles
time frame: instant

Eligibility Criteria

Male or female participants at least 18 years old.

Inclusion Criteria: - Hong Kong Chinese with confirmed IFG or IGT by OGTT Exclusion Criteria: - Confirmed diabetic patients

Additional Information

Official title A Survey to Evaluate the Cardiovascular Risk Status of Subjects With Pre-Diabetes in Hong Kong: The Joint Asia Diabetes Evaluation (JADE) Program Sub-study 2 (JADE-HK2)
Trial information was received from ClinicalTrials.gov and was last updated in August 2015.
Information provided to ClinicalTrials.gov by Chinese University of Hong Kong.